Amphastar Pharmaceuticals, Inc. Common Stock (NASDAQ: AMPH) last traded at $21.60, down 0.37% on the session. The quote above updates while this page is open; the figures below are drawn from Amphastar Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Amphastar Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker AMPH. Its market capitalisation is $918.82 million.
Valuation measures for Amphastar Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $918.82M |
|---|---|
| Enterprise value | $1.67B |
| P/E ratio | 12.78 |
| Price / sales | 1.26 |
| Beta | 0.59 |
Trailing-twelve-month figures tagged in Amphastar Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $730.02M |
|---|---|
| Net income (TTM) | $78.55M |
| EPS (TTM) | $1.69 |
| Gross margin | 47.68% |
| Operating margin | 15.66% |
| Cash | $223.61M |
Range and volume for AMPH over the past 52 weeks.
| 52-week high | $31.26 |
|---|---|
| 52-week low | $16.65 |
| Volume | 324.4K |
| Average volume | 521.2K |
| Previous close | $21.68 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.